Biocon shares in focus as Q4 PAT soars 153% YoY

[hfe_template id='11223'] [ad_1]
Biocon shares are expected to be in the spotlight on Friday, May 9, after the company reported a significant 153% year-on-year (YoY) surge in its net profit to Rs 344 crore for the fourth quarter of the financial year 2025.

Additionally, the company also posted consolidated revenue of Rs 4,454 crore, marking a 15% YoY increase on a like-for-like basis. The operating revenue rose by 15% to Rs 4,417 crore, after adjusting for BFI revenue.


EBITDA surged by 16% to Rs 1,115 crore, with an EBITDA margin of 25%. Core EBITDA increased by 16% to Rs 1,363 crore, reflecting a core EBITDA margin of 31%.

Additionally, Biocon invested Rs 231 crore in net R&D, representing 7% of revenue, excluding Syngene.


Segment-wise, the Generics division, encompassing APIs and generic formulations, delivered revenue of Rs 1,048 crore, up 46% year-on-year. The Research Services segment, represented by Syngene, recorded Rs 1,018 crore in revenue, an 11% rise.

The Biosimilars division, Biocon Biologics, posted revenue of Rs 2,463 crore, up 9% YoY on a like-for-like basis, after adjusting for BFI revenues and licensing income.Also read: Can M&M maintain its growth momentum with new product launches?

For the full financial year, Biocon’s net profit rose 30% YoY to Rs 1,013 crore, while its consolidated revenue grew 5% YoY to Rs 16,470 crore.

“FY25 has been a year of consolidation and transition. We are now on a path of accelerating growth with a commitment to innovation, digital augmentation and operational excellence,” said Kiran Mazumdar-Shaw, Chairperson of Biocon Group, while commenting on the Q4 results.

On Thursday, the shares of Biocon closed 3.5% lower at Rs 334.60 on the BSE.

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)

[ad_2] Source link https://mrgaga.in/biocon-shares-in-focus-as-q4-pat-soars-153-yoy/?feed_id=48684&_unique_id=681dbf582936a

Comments

Post a Comment

Popular posts from this blog

India VIX jumps 100% in one month. Could fear levels take Nifty further down?

Image
[hfe_template id='11223'] [ad_1] Volatility in Indian equity markets has surged sharply over the past month, with the India VIX nearly doubling as geopolitical tensions and global uncertainty triggered aggressive selling in equities. India VIX, often referred to as the market’s fear gauge, has jumped close to 100% over the past month, reflecting growing nervousness among investors. The spike has coincided with a sharp correction in the broader market, with the Nifty 50 declining about 8% during the same period. The escalation of tensions involving the United States, Israel and Iran has intensified market anxiety in recent days, pushing crude oil prices sharply higher and triggering a global risk-off sentiment. However, analysts note that volatility had already been building even before the conflict escalated, reflecting broader concerns around global growth, foreign capital outflows and stretched valuations in equities. The heightened uncertainty translated into a sharp ...
Read more

Can Sensex, Nifty snap 2-day fall on Monday? 7 factors that could decide market mood this week

Image
[hfe_template id='11223'] [ad_1] Benchmark indices Sensex and Nifty ended the week on a bearish note, closing over a percent lower each as a deepening selloff in IT stocks rattled investor sentiment amid mounting fears of AI-led disruption. Further, stronger-than-expected jobs data for January dampened hopes of a US Fed interest rate cut. Here are 7 factors that could decide market action in the coming week: 1.) Infosys, Wipro ADRs rebound - After a brutal two-day selloff that saw Infosys and Wipro ADRs plunge as much as 14.5%, Friday’s session brought a much-needed breather. Bargain hunting kicked in at lower levels, sparking a sharp rebound as Infosys climbed 3% while Wipro gained 4%—helping both stocks close the week on a far stronger note. International brokerage firm JP Morgan has a message for panic-stricken investors: IT services firms are the indispensable "plumbers of the tech world" and their dividend yields have now hit levels last seen only during ...
Read more

Waaree Energies shares in focus after Q4 profit rises 34% to Rs 619 crore, revenue up 36%

Image
[hfe_template id='11223'] [ad_1] Waaree Energies shares will be in focus on Wednesday after the solar panel maker reported a strong Q4 performance, with net profit rising 34.1% year-on-year (YoY) to Rs 618.9 crore for the quarter ended March 31, 2025. In the same quarter last year, the company had reported a profit of Rs 461.5 crore. Revenue from operations jumped 36.4% to Rs 4,003.9 crore, up from Rs 2,935.8 crore in the year-ago period, according to the company’s regulatory filing. EBITDA more than doubled to Rs 922.6 crore in Q4 FY25, up 120.6% from Rs 418.3 crore in the same quarter last year. The EBITDA margin improved to 23% from 14.3% a year ago. The company produced 2.06 GW of solar modules in the fourth quarter, up from 1.35 GW in the same period last year. For the full year, module production reached 7.13 GW, compared to 4.77 GW in FY24. For the full financial year FY25, revenue rose 27.62% YoY to Rs 14,846.06 crore. Profit after tax more than doubled to Rs 1,9...
Read more